Risk factors for psychosis: Impaired social and role functioning

Schizophrenia Bulletin

Volumn 38, Issue 6, 2012, Pages 1247-1257

  Cornblatt, Barbara A ^a,b,c   Carrión, Ricardo E ^a,c   Addington, Jean ^d   Seidman, Larry ^e,f   Walker, Elaine F ^g   Cannon, Tyronne D ^h   Cadenhead, Kristin S ⁱ   McGlashan, Thomas H ^j   Perkins, Diana O ^k   Tsuang, Ming T ^i,l   Woods, Scott W ^j   Heinssen, Robert ^m   Lencz, Todd ^a,b,c  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g EMORY UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^l HARVARD UNIVERSITY   (United States)

^m NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

more..

Author keywords

clinical high risk; functional deficits; functional outcome attenuated positive symptoms; prodromal; social risk factors

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; FUNCTIONAL DISEASE; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; RISK FACTOR; ROLE FUNCTIONING; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

ADOLESCENT; CASE-CONTROL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; ODDS RATIO; PRODROMAL SYMPTOMS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RISK FACTORS; ROLE; SOCIAL ADJUSTMENT; SOCIAL BEHAVIOR; SOCIAL BEHAVIOR DISORDERS; YOUNG ADULT;

EID: 84866691950     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbr136     Document Type: Article

References (44)

1. Cornblatt B, Lencz T, Smith C, Auther A. Treatment of the schizophrenia prodrome. In: Tsuang MT, Stone WS, Lyons MJ, eds. Recognition and Prevention of Major Mental and Substance Use Disorders. 1st ed Washington, DC: American Psychiatric Publishing; 2007:159-185.
2. Carpenter WT, Jr., Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145:578-583.
3. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ''right stuff ''? Schizophr Bull. 2000;26:119-136.
4. Harvey PD, Reichenberg A, Bowie CR, Patterson TL, Heaton RK. The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stay. Biol Psychiatry. 2010;67:933-939.
5. Hamilton SH, Edgell ET, Revicki DA, Breier A. Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample. Int Clin Psychopharmacol. 2000;15:245-255.
6. Bond GR, Kim HW, Meyer PS, et al. Response to vocational rehabilitation during treatment with first-or second-generation antipsychotics. Psychiatr Serv. 2004;55:59-66.
7. Rosenheck RA, Leslie DL, Sindelar J, et al. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. Am J Psychiatry. 2006;163:2080-2089.
8. Bellack AS, Gold JM, Buchanan RW. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. Schizophr Bull. 1999;25:257-274.
9. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996; 153:321-330.
10. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72:41-51.
11. Niendam TA, Bearden CE, Zinberg J, Johnson JK, O'Brien M, Cannon TD. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophr Bull. 2007;33:772-781.
12. Bowie CR, Leung WW, Reichenberg A, et al. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry. 2008;63:505-511.
13. Harvey PD, Helldin L, Bowie CR, et al. Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden. Am J Psychiatry. 2009;166:821-827.
14. Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res. 2008;99:119-124.
15. Cannon M, Jones P, Huttunen MO, et al. School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch Gen Psychiatry. 1999;56:457-463.
16. Done DJ, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ. 1994;309:699-703.
17. Dworkin RH, Green SR, Small NE, Warner ML, Cornblatt BA, Erlenmeyer-Kimling L. Positive and negative symptoms and social competence in adolescents at risk for schizophrenia and affective disorder. Am J Psychiatry. 1990;147:1234-1236.
18. Dworkin RH, Lewis JA, Cornblatt BA, Erlenmeyer-Kimling L. Social competence deficits in adolescents at risk for schizophrenia. J Nerv Ment Dis. 1994;182:103-108.
19. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398-1402.
20. Hans SL, Auerbach JG, Asarnow JR, Styr B, Marcus J. Social adjustment of adolescents at risk for schizophrenia: the Jerusalem Infant Development Study. J Am Acad Child Adolesc Psychiatry. 2000;39:1406-1414.
21. Tarbox SI, Pogue-Geile MF. Development of social functioning in preschizophrenia children and adolescents: a systematic review. Psychol Bull. 2008;134:561-583.
22. Ruhrmann S, Schultze-Lutter F, Salokangas RK, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry. 2010;67:241-251.
23. Hafner H, Nowotny B. Epidemiology of early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 1995;245:80-92.
24. Cornblatt BA, Auther AM, Niendam T, et al. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull. 2007;33:688-702.
25. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008; 65:28-37.
26. Riecher-Ro ssler A, Pflueger MO, Aston J, et al. Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry. 2009;66:1023-1030.
27. Ruhrmann S, Schultze-Lutter F, Klosterkotter J. Probably at-risk, but certainly ill-advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res. 2010; 120:23-37.
28. Velthorst E, Nieman DH, Linszen D, et al. Disability in people clinically at high risk of psychosis. Br J Psychiatry. 2010; 197:278-284.
29. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull. 2003;29:633-651.
30. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353-370.
31. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703-715.
32. Addington J, Cadenhead KS, Cannon TD, et al. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007;33:665-672.
33. Woods SW, Addington J, Cadenhead KS, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009;35:894-908.
34. Seidman LJ, Giuliano AJ, Meyer EC, et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry. 2010;67:578-588.
35. Auther A, Smith C, Cornblatt B. Global Functioning Scale: Social (GFS: Social). Glen Oaks, NY: Zucker-Hillside Hospital; 2006.
36. Niendam TA, Bearden CE, Johnson JK, Cannon TD. Global Functioning Scale: Role (GFS: Role). Los Angeles. University of California; 2006.
37. Addington J, Cornblatt BA, Cadenhead KS, et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry. 2011;168:800-805.
38. Piskulic D, Addington J, Auther A, Cornblatt BA. Using the global functioning social and role scales in a first-episode sample. Early Interv Psychiatry. 2011;5:219-223.
39. Hanley JA, Negassa A, Edwardes MD, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003;157:364-375.
40. Diggle P, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. New York, NY: Oxford University Press; 1994.
41. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
42. Corcoran CM, Kimhy D, Parrilla-Escobar MA, et al. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol Med. 2011;41:251-261.
43. Cornblatt BA, Lencz T, Smith CW, et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry. 2007;68:546-557.
44. Carrion RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA. Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. Am J Psychiatry. 2011;168:806-813.